Suchergebnisse - "Cantini, Fabrizio"

PubPharm (73)

1

Non-medical switching : save today and pay tomorrow

enthalten in: Journal of medical economics | 2019

von Benucci, M. | Cantini, F.

CommentOn: J Med Econ. 2019 Nov;22(11):1162-1170. - PMID 31373527

2

Biosimilars for the treatment of psoriatic arthritis

enthalten in: Expert review of clinical immunology | 2019

von Cantini, F. | Benucci, M. | Li Gobbi, F. | +2

3

Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis : an open-label, 18-month, prospective, pilot study

enthalten in: Annals of the rheumatic diseases | 2019

von Nannini, C. | Niccoli, L. | Sestini, S. | +3

CommentIn: Ann Rheum Dis. 2021 Nov;80(11):e184. - PMID 31690621

4

Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases

enthalten in: The Journal of infection | 2019

von Chiacchio, T. | Petruccioli, E. | Vanini, V. | +11

5

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

6

Additional comment to : 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

7

Switching from the bio-originators to biosimilar : is it premature to recommend this procedure?

enthalten in: Annals of the rheumatic diseases | 2019

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648

8

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis : An Italian Real-Life Retrospective Study

enthalten in: Frontiers in pharmacology | 2019

von D'Angelo, S. | Cantini, F. | Ramonda, R. | +29

9

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

10

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

enthalten in: Expert review of anti-infective therapy | 2018

von Goletti, D. | Petrone, L. | Ippolito, G. | +3

1
2
3
4
5
6
7
8
Nächster »
[8]